AAO

In Case You Missed It: AAO 2022 Retina Hot Topics

GATHER 2: Avacincaptas pegol shows growth reduction in geographic atrophy The investigation geographic atrophy (GA) therapy avacincaptas pegol effectively slowed the rate of GA growth in patients with the disease, according to data from the Phase 3 GATHER 2 trial. This is the first time an investigation therapy in GA...